Physiological characterization of a novel PPAR pan agonist, 2-(4-(5,6-methylenedioxybenzo[d]thiazol-2-yl)-2-methylphenoxy)-2-methylpropanoic acid (MHY2013)

Recently, agonists targeting multiple peroxisome proliferator-activated receptors (PPARs) have been developed to improve metabolic disorders and minimize the side effects of selective PPAR agonists such as weight gain and dyslipidemia. We newly synthesized six 2-methyl-2-(o-tolyloxy)propanoic acid d...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oncotarget
Main Authors: An, Hye Jin, Lee, Bonggi, Kim, Dae Hyun, Lee, Eun Kyeong, Chung, Ki Wung, Park, Min Hi, Jeong, Hyoung Oh, Kim, Sung Min, Moon, Kyoung Mi, Kim, Ye Ra, Kim, Seong Jin, Yun, Hwi Young, Chun, Pusoon, Yu, Byung Pal, Moon, Hyung Ryong, Chung, Hae Young
Formato: Artigo
Idioma:Inglês
Publicado: Impact Journals LLC 2017
Assuntos:
Research Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5370010/
https://ncbi.nlm.nih.gov/pubmed/28129657
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.14818
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares